Clinical Trials in Massachusetts

Showing 2261-2280 of 15,316 trials

International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)

NCT06174727

This multicenter retrospective cohort study aims to evaluate and compare the technical performance, safety, and clinical outcomes of intracranial aneurysms treated with flow diverter stents and endosaccular flow disruptors.

Intracranial Aneurysm

Montefiore Medical Center5,000 participantsStarted Oct 2023

Coral Gables, Florida, United States • Jacksonville, Florida, United States • Sarasota, Florida, United States +8 more locations

COMPLETEDPhase 126 miles

Study of Regorafenib in Patients With Advanced Myeloid Malignancies

NCT03042689

This research study is studying a drug as a possible treatment for advanced myeloid malignancies including AML (acute myeloid leukemia), MDS (myelodysplastic syndrome) and MPN (myeloproliferative neoplasms) The intervention involved in this study is: -Regorafenib (Stivarga)

Acute Myeloid Leukemia

Massachusetts General Hospital16 participantsStarted Apr 2017

Boston, Massachusetts, United States

Active Not RecruitingNA26 miles

Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study

NCT05291884

This is a prospective, multi-center, single-arm, early feasibility study that aims to evaluate the safety of the Impella BTR™ in adult patients requiring left-ventricular hemodynamic support, and to evaluate the effectiveness of the Impella BTR™ in supporting patients to recovery or their next therapy.

Heart FailureAcute Decompensated Heart Failure

Abiomed Inc.10 participantsStarted Apr 2022

Atlanta, Georgia, United States • Evanston, Illinois, United States • Boston, Massachusetts, United States +3 more locations

International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)

Study of Regorafenib in Patients With Advanced Myeloid Malignancies

Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study

Find Trials by Condition in Massachusetts

A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma

Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy

ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL

Allied Cleft & Craniofacial Quality-Improvement and Research Network (ACCQUIREnet)

Neutrophil Phenotypic Profiling and Organ Injury Assessment in Patients With Sepsis

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

The Exercise and Concussion Health Study

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy

A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus

Biodesign® Otologic Repair Graft

A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)

Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.